India’s Life Sciences & Healthcare GCCs have evolved from mere operational hubs into strategic drivers of global healthcare innovation. Now concentrated—over 85%—in Bengaluru, Hyderabad, Mumbai, and Delhi-NCR, they lead high-value functions such as drug discovery, clinical development, regulatory affairs, digital transformation, and commercial strategy by leveraging India’s rich talent, advanced digital ecosystem, and cost advantages.
Healthark’s report, Expanding Horizons – The Maturity Journey of Life Sciences & Healthcare GCCs in India, outlines this evolution. It explains how GCCs have transitioned from process-centered, capacity-driven models to innovation-led, strategic partners. The report presents a capability-based maturity framework, mapping GCCs based on their impact and functional depth, and identifies key challenges like talent retention and regulatory complexities while offering actionable insights for long-term global growth.
